Answers are grounded in this paper and cite their sources.
BACKGROUND: Approximately 20% of adolescents and young adults (AYA: ages 15-39) with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) are diagnosed with metastatic disease, which has a dismal prognosis. Optimal care is critical to improve outcomes, but there is no consensus on the best management approach. We sought to evaluate multimodality care (MMC) and survival among AYAs with metastatic NRSTS. METHODS: We identified AYAs diagnosed during 2004-2022 with metastatic NRSTS in the California Cancer Registry. We defined MMC as first-line treatment receipt of surgery, chemotherapy, and radiation per the Children's Oncology Group ARST0332 protocol. We used multivariable logistic regression to evaluate associations of sociodemographic and clinical factors with receipt of MMC, and multivariable Cox proportional hazards regression to examine the impact of MMC on overall survival. RESULTS: Of the 726 AYAs with metastatic NRSTS, 14% received MMC. A larger proportion of patients 15-25 years old who were treated by pediatric (vs. medical) oncologists received chemotherapy (96% vs. 75%), radiation (53% vs. 34%), and chemoradiation (51% vs. 25%). Older age (>21 years) was associated with decreased odds of receiving MMC. In patients ages 15-25, treatment by a pediatric (vs. medical) oncologist was associated with higher odds of receiving MMC (odds ratio [OR] = 3.4, 95% confidence interval [CI]: 1.33-8.72). Median overall survival was longer for patients receiving MMC (2.1 vs. 1.1 years), although associations did not remain statistically significant in the multivariable-adjusted model (HR = 0.89, CI = 0.68-1.16). Receiving all care at a specialized cancer center was associated with improved overall survival (HR = 0.63, CI = 0.49-0.81). CONCLUSION: We found that only 14% of AYAs with metastatic NRSTS received MMC, which was impacted by age at diagnosis and physician specialty. Future research should investigate decision-making in patients with metastatic NRSTS and their providers, and its impact on outcomes.
No takes yet. Share an insight, caveat, or question.
Alvarez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: